
Albireo Pharma ALBO
Quartalsbericht 2022-Q3
hinzugefügt 08.11.2022
Albireo Pharma P/E 2011-2026 | ALBO
P/E Jährlich Albireo Pharma
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -15.8 | -6.5 | -4.33 | -6.16 | -11.4 | -2.89 | -0.81 | -2.32 | -2.05 | -1.48 | -2.41 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.81 | -15.8 | -5.1 |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
BioNTech SE
BNTX
|
6.11 | $ 97.54 | 2.14 % | $ 27.2 B | ||
|
Aligos Therapeutics
ALGS
|
-2.73 | $ 8.65 | 8.19 % | $ 85.5 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-66.5 | $ 3.63 | -2.42 % | $ 8.73 B | ||
|
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
-0.189 | - | 4.14 % | $ 49.1 M | ||
|
Applied Molecular Transport
AMTI
|
-0.175 | - | - | $ 10.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
2.49 K | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Applied Therapeutics
APLT
|
-4.52 | - | - | $ 8.42 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
-24.7 | $ 2.14 | -1.38 % | $ 445 M | ||
|
Evogene Ltd.
EVGN
|
-2.18 | $ 0.81 | -0.07 % | $ 27.9 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
12.7 | $ 20.47 | 0.49 % | $ 957 M | ||
|
Genmab A/S
GMAB
|
33.2 | $ 28.2 | -0.18 % | $ 18 B | ||
|
Grifols, S.A.
GRFS
|
31.7 | $ 8.19 | -0.24 % | $ 6.83 B | ||
|
GT Biopharma
GTBP
|
-0.0914 | $ 0.36 | -2.82 % | $ 1.98 M | ||
|
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
Halozyme Therapeutics
HALO
|
30.5 | $ 67.06 | -1.12 % | $ 8.04 B | ||
|
Adverum Biotechnologies
ADVM
|
-0.583 | - | - | $ 86.2 M | ||
|
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K | ||
|
Harmony Biosciences Holdings
HRMY
|
10.1 | $ 28.69 | -0.69 % | $ 1.65 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
-62.5 | $ 1.41 | 0.71 % | $ 363 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | ||
|
Allakos
ALLK
|
-0.612 | - | - | $ 28.6 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.489 | $ 2.96 | 1.37 % | $ 4.87 M | ||
|
Aptinyx
APTX
|
-0.146 | - | -39.0 % | $ 4.57 M | ||
|
Aquestive Therapeutics
AQST
|
-5.58 | $ 4.16 | 1.84 % | $ 445 M | ||
|
Aravive
ARAV
|
-0.791 | - | -13.39 % | $ 1.45 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-213 | $ 24.01 | -0.85 % | $ 3.05 B | ||
|
ImmuCell Corporation
ICCC
|
-55.8 | $ 7.12 | 1.14 % | $ 64.3 M | ||
|
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | ||
|
Celldex Therapeutics
CLDX
|
-7.88 | $ 32.24 | - | $ 2.14 B | ||
|
Autolus Therapeutics plc
AUTL
|
-1.12 | $ 1.48 | -0.67 % | $ 394 M | ||
|
Aptose Biosciences
APTO
|
-0.0913 | - | -45.71 % | $ 1.2 M | ||
|
Immatics N.V.
IMTX
|
-5.39 | $ 10.48 | 0.43 % | $ 659 M | ||
|
Cidara Therapeutics
CDTX
|
-0.873 | - | - | $ 1.41 B | ||
|
Incyte Corporation
INCY
|
15.1 | $ 94.86 | -1.26 % | $ 18.5 B | ||
|
AVROBIO
AVRO
|
4.63 | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-1.16 | $ 2.61 | 2.35 % | $ 16.4 M | ||
|
InflaRx N.V.
IFRX
|
-3.26 | $ 1.05 | 4.5 % | $ 152 M | ||
|
AstraZeneca PLC
AZN
|
706 | - | - | $ 96.9 B | ||
|
Inventiva S.A.
IVA
|
-10.8 | $ 5.18 | -1.52 % | $ 138 M |